Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

933.888
-1.516-0.16%
Number of Gainers:4
Number of Losers:12
Number of Flat:1
PE:- -
High:943.269
Open:936.194
Low:926.980
Close:935.404
Volume:277.30M
Turnover:2.51B
Market Cap:628.70B
Float Cap:522.84B

Loading ...

Fosun Pharma's H1 Report: Innovative Drug Revenue Surges 13.8% as Global Expansion Spans Three Continents

Deep News
·
Aug 26

HK Stock Alert | TH MEDICAL-B Surges Over 6% on Northeast China Oncology Partnership, Accelerating Commercial Momentum

Stock News
·
Aug 26

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

Stock News
·
Aug 26

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Aug 26

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Stock News
·
Aug 26

Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million

THOMSON REUTERS
·
Aug 26

Sihuan Pharma Appoints Song Xiaomi as CFO

Reuters
·
Aug 26

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS
·
Aug 26

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS
·
Aug 26

Waterdrop's Yifan Medicine Cracks Clinical Recruitment Hurdle in Extensive-Stage Small Cell Lung Cancer, Setting a New Service Benchmark

Stock News
·
Aug 26

HK Biotech Shares Surge as CansinoBio Jumps Over 18%

Deep News
·
Aug 26

Finally Tasting the Gains in the Healthcare Sector Today!

Deep News
·
Aug 26

Fosun Pharma Posts Flat Profit Growth in H1, Revenue Up 4.8%

MT Newswires Live
·
Aug 26

Press Release: Fosun Pharma Announces 2026 Interim Results

Dow Jones
·
Aug 25

ETF Market Daily: Healthcare Sector Shows Solid Valuations While Innovative Drug Subsegments See Dense Catalysts, Spotlight on Hang Seng Biotech ETF and STAR Innovative Drug ETF

Deep News
·
Aug 25

CSPC Pharma's Recombinant RSV Vaccine Wins US Clinical Trial Clearance

Stock News
·
Aug 25

CSPC Says FDA Clears RSV Vaccine Candidate SYS 6057 for US Clinical Trial

Reuters
·
Aug 25

CSPC Pharmaceutical - Recombinant Respiratory Syncytial Virus Vaccine (Sys6057) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
Aug 25

CSPC Pharmaceutical - Sys6057 Receives Nmpa Approval on July 30, 2026 to Conduct Clinical Trials in China

THOMSON REUTERS
·
Aug 25

Sinopharm Group (SEHK:1099) Stock Drifts As Stable Earnings Meet Thin Margins

Simply Wall St.
·
Aug 25